References
- Borgert CJ, Mihaich EM, Ortego LS, Bentley KS, Holmes CM, Levine SL et al. (2011). Hypothesis-driven weight of evidence framework for evaluating data within the US EPA’s Endocrine Disruptor Screening Program. Regul Toxicol Pharmacol 61:185–191.
- Kortenkamp A, Martin O, Faust M, Evans R, McKinlay R, Orton F, Rosivatz E. (2011). State of the Art Assessment of Endocrine Disrupters. Final Report. Available at: http://ec.europa.eu/environment/endocrine/documents/4_SOTA%20EDC%20Final%20Report%20V3%206%20Feb%2012.pdf. Accessed on: 12 March 2012.
- Kortenkamp A, Martin O, Evans R, Orton F, McKinlay R, Rosivatz E, Faust M. (in press). Response to A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues. Crit Rev Toxicol.
- Rhomberg LR, Bailey LA, Goodman JE. (2010). Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action–naphthalene as an example. Crit Rev Toxicol 40:671–696.
- Rhomberg LR, Goodman JE, Foster WG, Borgert CJ, Van Der Kraak G. (2012). A critique of the European Commission Document, “State of the Art Assessment of Endocrine Disrupters”. Crit Rev Toxicol 42:465–473.
- WHO (World Health Organization)/International Programme on Chemical Safety (IPCS). (2002). Global Assessment of the State-of-the-science of Endocrine Disruptors. Available at: http://www.who.int/ipcs/publications/new_issues/endocrine_disruptors/en/. Accessed on: 4 October 2002.